Bedoukian   RussellIPM   RussellIPM   Piezoelectric Micro-Sprayer


Home
Animal Taxa
Plant Taxa
Semiochemicals
Floral Compounds
Semiochemical Detail
Semiochemicals & Taxa
Synthesis
Control
Invasive spp.
References

Abstract

Guide

Alphascents
Pherobio
InsectScience
E-Econex
Counterpart-Semiochemicals
Print
Email to a Friend
Kindly Donate for The Pherobase

« Previous AbstractExternal validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease    Next AbstractHuman breath emissions of VOCs »

Clin Exp Allergy


Title:Exhaled breath analysis by electronic nose in airways disease. Established issues and key questions
Author(s):Fens N; van der Schee MP; Brinkman P; Sterk PJ;
Address:"Dept. of Respiratory Medicine, Academic Medical Centre, University of Amsterdam, P.O. Box 22700, NL-1100 DE, Amsterdam, The Netherlands. N.Fens@amc.uva.nl"
Journal Title:Clin Exp Allergy
Year:2013
Volume:43
Issue:7
Page Number:705 - 715
DOI: 10.1111/cea.12052
ISSN/ISBN:1365-2222 (Electronic) 0954-7894 (Linking)
Abstract:"Exhaled air contains many volatile organic compounds (VOCs) that are the result of normal and disease-associated metabolic processes anywhere in the body. Different omics techniques can assess the pattern of these VOCs. One such omics technique suitable for breath analysis is represented by electronic noses (eNoses), providing fingerprints of the exhaled VOCs, called breathprints. Breathprints have been shown to be altered in different disease states, including in asthma and COPD. This review describes the current status on clinical validation and application of breath analysis by electronic noses in the diagnosis and monitoring of chronic airways diseases. Furthermore, important methodological issues including breath sampling, modulating factors and incompatibility between eNoses are raised and discussed. Next steps towards clinical application of electronic noses are provided, including further validation in suspected disease, assessment of the influence of different comorbidities, the value in longitudinal monitoring of patients with asthma and COPD and the possibility to predict treatment responses. Eventually, a Breath Cloud may be constructed, a large database containing disease-specific breathprints. When collaborative efforts are put into optimization of this technique, it can provide a rapid and non-invasive first line diagnostic test"
Keywords:"Asthma/*diagnosis/*metabolism Databases, Factual *Electronic Nose *Exhalation Humans Monitoring, Physiologic/instrumentation/methods Volatile Organic Compounds/analysis/*metabolism;"
Notes:"MedlineFens, N van der Schee, M P Brinkman, P Sterk, P J eng Review England 2013/06/22 Clin Exp Allergy. 2013 Jul; 43(7):705-15. doi: 10.1111/cea.12052"

 
Back to top
 
Citation: El-Sayed AM 2024. The Pherobase: Database of Pheromones and Semiochemicals. <http://www.pherobase.com>.
© 2003-2024 The Pherobase - Extensive Database of Pheromones and Semiochemicals. Ashraf M. El-Sayed.
Page created on 06-07-2024